RCAMU
ACOR
Rothschild & Co Asset Management US’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-558,885
| Closed | -$11.7M | – | 593 |
|
|
2017
Q1 | $11.7M | Buy |
558,885
+11,965
| +2% | +$251K | 0.13% | 227 |
|
|
2016
Q4 | $10.3M | Buy |
546,920
+82,022
| +18% | +$1.54M | 0.13% | 232 |
|
|
2016
Q3 | $9.71M | Buy |
464,898
+29,555
| +7% | +$617K | 0.17% | 218 |
|
|
2016
Q2 | $11.1M | Buy |
435,343
+57,326
| +15% | +$1.46M | 0.2% | 189 |
|
|
2016
Q1 | $10M | Buy |
378,017
+22,678
| +6% | +$600K | 0.19% | 185 |
|
|
2015
Q4 | $15.2M | Buy |
355,339
+19,325
| +6% | +$827K | 0.28% | 114 |
|
|
2015
Q3 | $8.91M | Buy |
336,014
+71,470
| +27% | +$1.89M | 0.17% | 197 |
|
|
2015
Q2 | $8.82M | Buy |
264,544
+3,832
| +1% | +$128K | 0.16% | 209 |
|
|
2015
Q1 | $8.68M | Buy |
260,712
+162,141
| +164% | +$5.4M | 0.16% | 208 |
|
|
2014
Q4 | $4.03M | Buy |
98,571
+706
| +0.7% | +$28.9K | 0.08% | 275 |
|
|
2014
Q3 | $3.32M | Sell |
97,865
-4,090
| -4% | -$139K | 0.07% | 292 |
|
|
2014
Q2 | $3.44M | Sell |
101,955
-2,737
| -3% | -$92.3K | 0.07% | 302 |
|
|
2014
Q1 | $3.97M | Sell |
104,692
-173,954
| -62% | -$6.59M | 0.09% | 301 |
|
|
2013
Q4 | $8.14M | Buy |
278,646
+2,874
| +1% | +$83.9K | 0.18% | 204 |
|
|
2013
Q3 | $9.43M | Sell |
275,772
-156
| -0.1% | -$5.34K | 0.21% | 168 |
|
|
2013
Q2 | $9.1M | Buy |
+275,928
| New | +$9.1M | 0.21% | 164 |
|